ID28953A - 4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinal - Google Patents
4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinalInfo
- Publication number
- ID28953A ID28953A IDW00200101336A ID20011336A ID28953A ID 28953 A ID28953 A ID 28953A ID W00200101336 A IDW00200101336 A ID W00200101336A ID 20011336 A ID20011336 A ID 20011336A ID 28953 A ID28953 A ID 28953A
- Authority
- ID
- Indonesia
- Prior art keywords
- aminometyl
- benzamide
- piperidine
- gastrointestinal disorders
- treat gastrointestinal
- Prior art date
Links
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 2
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98204411 | 1998-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID28953A true ID28953A (id) | 2001-07-19 |
Family
ID=8234539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW00200101336A ID28953A (id) | 1998-12-22 | 1999-12-14 | 4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinal |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6544997B1 (cs) |
| EP (1) | EP1140915B1 (cs) |
| JP (1) | JP4615725B2 (cs) |
| KR (1) | KR100633680B1 (cs) |
| CN (1) | CN1150190C (cs) |
| AR (1) | AR024240A1 (cs) |
| AT (1) | ATE297917T1 (cs) |
| AU (1) | AU770397B2 (cs) |
| BG (1) | BG64953B1 (cs) |
| BR (1) | BR9916491A (cs) |
| CA (1) | CA2355857C (cs) |
| CZ (1) | CZ300851B6 (cs) |
| DE (1) | DE69925865T2 (cs) |
| DK (1) | DK1140915T3 (cs) |
| EA (1) | EA003608B1 (cs) |
| EE (1) | EE200100335A (cs) |
| ES (1) | ES2245131T3 (cs) |
| HK (1) | HK1039114B (cs) |
| HR (1) | HRP20010445A2 (cs) |
| HU (1) | HUP0104838A3 (cs) |
| ID (1) | ID28953A (cs) |
| IL (1) | IL143858A (cs) |
| MY (1) | MY121852A (cs) |
| NO (1) | NO321324B1 (cs) |
| NZ (1) | NZ512871A (cs) |
| PL (1) | PL197409B1 (cs) |
| PT (1) | PT1140915E (cs) |
| SI (1) | SI1140915T1 (cs) |
| SK (1) | SK285829B6 (cs) |
| TR (1) | TR200101962T2 (cs) |
| TW (1) | TW570920B (cs) |
| UA (1) | UA71591C2 (cs) |
| WO (1) | WO2000037461A1 (cs) |
| ZA (1) | ZA200105135B (cs) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002335161A1 (en) * | 2002-09-12 | 2004-04-30 | Nagase Chemtex Corporation | Medicinal composition |
| CA2528653C (en) * | 2003-06-19 | 2012-01-10 | Janssen Pharmaceutica N.V. | Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| EP1641783B1 (en) | 2003-06-19 | 2012-03-28 | Janssen Pharmaceutica NV | Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| KR20060022702A (ko) | 2003-06-19 | 2006-03-10 | 얀센 파마슈티카 엔.브이. | 5ｈｔ4-길항성 4-(아미노메틸)-피페리딘벤즈아미드 |
| JO2478B1 (en) | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
| AU2004254190B2 (en) | 2003-06-19 | 2010-04-22 | Janssen Pharmaceutica N.V. | Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists |
| PT1664036E (pt) | 2003-09-03 | 2012-02-16 | Pfizer | Compostos de benzimidazolona que possuem actividade agonística do receptor 5-ht4 |
| DE602004026095D1 (de) * | 2003-11-24 | 2010-04-29 | Pfizer | Chinoloncarbonsäureverbindungen mit 5-ht4-rezeptoragonistischer wirkung |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| EA200801608A1 (ru) | 2004-06-15 | 2008-10-30 | Пфайзер Инк. | Производные бензимидазолонкарбоновой кислоты |
| US20060035890A1 (en) * | 2004-08-10 | 2006-02-16 | Amit Banerjee | Compounds and methods for the treatment of ubiquitin conjugating disorders |
| US7399862B2 (en) * | 2004-11-05 | 2008-07-15 | Theravance, Inc. | 5-HT4 receptor agonist compounds |
| WO2006052889A2 (en) * | 2004-11-05 | 2006-05-18 | Theravance, Inc. | Quinolinone-carboxamide compounds |
| ES2347265T3 (es) * | 2004-12-22 | 2010-10-27 | Theravance, Inc. | Compuestos de indazol-carboxamida. |
| MX2007010769A (es) * | 2005-03-02 | 2008-03-07 | Theravance Inc | Compuestos de quinolina como agonistas de receptor 5-ht4. |
| US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
| US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
| US8377968B2 (en) | 2008-06-02 | 2013-02-19 | Zalicus Pharmaceuticals, Ltd. | N-piperidinyl acetamide derivatives as calcium channel blockers |
| US10208023B2 (en) | 2013-03-01 | 2019-02-19 | Mark G. DeGiacomo | Heterocyclic inhibitors of the sodium channel |
| US20180305334A1 (en) * | 2015-10-14 | 2018-10-25 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
| JP2022540253A (ja) | 2019-07-11 | 2022-09-14 | プラクシス プレシジョン メディシンズ， インコーポレイテッド | Ｔ型カルシウムチャネル調節因子の製剤およびその使用方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ225152A (en) * | 1987-07-17 | 1990-04-26 | Janssen Pharmaceutica Nv | Heterocyclically substituted piperidinyl benzamides as pharmaceuticals |
| CA1317940C (en) * | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
| US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| JPH06510283A (ja) | 1991-08-20 | 1994-11-17 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５−ｈｔ４レセプター拮抗薬 |
| JP3294611B2 (ja) * | 1991-09-12 | 2002-06-24 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５−ｈｔ４レセプター・アンタゴニスト |
| DK0577847T3 (da) * | 1992-01-23 | 1999-06-23 | Toray Industries | Morphinanderivat og medicinsk anvendelse deraf |
| JPH07503480A (ja) * | 1992-02-06 | 1995-04-13 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５−ｈｔ４拮抗薬としてのベンゾピラン，ベンゾチオピランおよびベンゾフラン誘導体 |
| GB9219163D0 (en) | 1992-09-10 | 1992-10-28 | Smithkline Beecham Plc | Pharmaceuticals |
| JPH08502273A (ja) | 1992-10-13 | 1996-03-12 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５−ｈｔ▲下４▼レセプターアンタゴニスト用複素環式エステルまたはアミド |
| MX9306311A (es) | 1992-10-13 | 1994-04-29 | Smithkline Beecham Plc | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
| NZ257545A (en) | 1992-11-05 | 1997-01-29 | Smithkline Beecham Plc | Heterocyclic (especially piperidine) derivatives and pharmaceutical compositions |
| GB9301660D0 (en) * | 1993-01-28 | 1993-03-17 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9312348D0 (en) | 1993-06-16 | 1993-07-28 | Smithkline Beecham Plc | Pharmaceuticals |
| ES2103675B1 (es) * | 1995-01-10 | 1998-07-01 | Almirall Lab | Nuevas piperidinas sustituidas. |
| IT1275903B1 (it) | 1995-03-14 | 1997-10-24 | Boehringer Ingelheim Italia | Esteri e ammidi della 1,4-piperidina disostituita |
| GB9507882D0 (en) | 1995-04-18 | 1995-05-31 | Pharmacia Spa | Substituted dihydrobenzofuran derivatives as 5-ht4 agonists |
| KR100469029B1 (ko) * | 1996-02-15 | 2005-05-27 | 얀센 파마슈티카 엔.브이. | 세로토닌재흡수억제제의위장효과를극복하기위한5ht4수용체길항제의용도 |
| TW445263B (en) * | 1996-02-29 | 2001-07-11 | Janssen Pharmaceutica Nv | Novel esters of 1,4-disubstituted piperidine derivatives |
| TW402591B (en) * | 1997-07-11 | 2000-08-21 | Janssen Pharmaceutica Nv | Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| EP1112270B1 (en) * | 1998-09-10 | 2007-03-21 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
| DE10217868A1 (de) * | 2002-04-22 | 2003-10-30 | Jomed N V | Ballon-Katheter |
-
1999
- 1999-12-03 TW TW088121125A patent/TW570920B/zh not_active IP Right Cessation
- 1999-12-14 CN CNB998147699A patent/CN1150190C/zh not_active Expired - Fee Related
- 1999-12-14 SI SI9930822T patent/SI1140915T1/sl unknown
- 1999-12-14 UA UA2001064399A patent/UA71591C2/uk unknown
- 1999-12-14 EE EEP200100335A patent/EE200100335A/xx unknown
- 1999-12-14 HU HU0104838A patent/HUP0104838A3/hu unknown
- 1999-12-14 PL PL348417A patent/PL197409B1/pl unknown
- 1999-12-14 NZ NZ512871A patent/NZ512871A/xx unknown
- 1999-12-14 IL IL14385899A patent/IL143858A/xx not_active IP Right Cessation
- 1999-12-14 ID IDW00200101336A patent/ID28953A/id unknown
- 1999-12-14 HK HK02100161.1A patent/HK1039114B/en not_active IP Right Cessation
- 1999-12-14 WO PCT/EP1999/010064 patent/WO2000037461A1/en active IP Right Grant
- 1999-12-14 US US09/857,905 patent/US6544997B1/en not_active Expired - Lifetime
- 1999-12-14 AT AT99967956T patent/ATE297917T1/de not_active IP Right Cessation
- 1999-12-14 AU AU24328/00A patent/AU770397B2/en not_active Ceased
- 1999-12-14 CZ CZ20012117A patent/CZ300851B6/cs not_active IP Right Cessation
- 1999-12-14 BR BR9916491-4A patent/BR9916491A/pt not_active Application Discontinuation
- 1999-12-14 DK DK99967956T patent/DK1140915T3/da active
- 1999-12-14 JP JP2000589532A patent/JP4615725B2/ja not_active Expired - Fee Related
- 1999-12-14 CA CA002355857A patent/CA2355857C/en not_active Expired - Fee Related
- 1999-12-14 EA EA200100710A patent/EA003608B1/ru not_active IP Right Cessation
- 1999-12-14 HR HR20010445A patent/HRP20010445A2/hr not_active Application Discontinuation
- 1999-12-14 ES ES99967956T patent/ES2245131T3/es not_active Expired - Lifetime
- 1999-12-14 TR TR2001/01962T patent/TR200101962T2/xx unknown
- 1999-12-14 PT PT99967956T patent/PT1140915E/pt unknown
- 1999-12-14 DE DE69925865T patent/DE69925865T2/de not_active Expired - Lifetime
- 1999-12-14 EP EP99967956A patent/EP1140915B1/en not_active Expired - Lifetime
- 1999-12-14 KR KR1020017005055A patent/KR100633680B1/ko not_active Expired - Fee Related
- 1999-12-14 SK SK859-2001A patent/SK285829B6/sk not_active IP Right Cessation
- 1999-12-17 MY MYPI99005534A patent/MY121852A/en unknown
- 1999-12-21 AR ARP990106644A patent/AR024240A1/es active IP Right Grant
-
2001
- 2001-06-07 BG BG105571A patent/BG64953B1/bg unknown
- 2001-06-08 NO NO20012858A patent/NO321324B1/no not_active IP Right Cessation
- 2001-06-21 ZA ZA200105135A patent/ZA200105135B/en unknown
-
2003
- 2003-01-29 US US10/353,307 patent/US7205410B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID28953A (id) | 4-(aminometil)-piperidina benzamida untuk mengobati gangguan gastrointestinal | |
| ID24481A (id) | Gastrokinetik monosiklik benzamida dari derivat-3-atau-tersubstitusi 4-(aminometil)-piperidin | |
| DE60121614D1 (de) | Nachweis von neurologischen funktionsstörungen | |
| DE60118908D1 (de) | Behandlung von mineralischen stoffen | |
| DE60136181D1 (de) | 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden | |
| DE60300021D1 (de) | (S)-4-Amino-5-Chloro-2-Methoxy-N-[1-[1-(2-Tetrahydrofuryl-Carbonyl)-4-Piperidinylmethyl]-4-Piperidinyl]benzamid zur Behandlung von Magen-Darmbewegungskrankheiten | |
| DK1165510T3 (da) | 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser | |
| DE59912795D1 (de) | Substituierte Benzamide und ihre Verwendung als Immunmodulatoren | |
| PL357674A1 (pl) | Kompozycje i sposoby leczenia zaburzeń związanychz hiperlipidemią | |
| NO20006547D0 (no) | Salter av paroxetine | |
| NO20032156L (no) | Behandling av angstforstyrrelser | |
| DE60019145D1 (de) | Verwendung von carbonylaminoderivaten gegen zentralnervensystem-störungen | |
| NO20003960D0 (no) | Salter av paroksetin | |
| ATE243197T1 (de) | Kristallformen von osanetant | |
| ATE317261T1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| DE60026931D1 (de) | Ausrichtung von Ausdrucken | |
| NO20010390D0 (no) | Behandling av angstsykdommer | |
| ATE256662T1 (de) | Amorphe modifikation von torasemid | |
| NO20014953L (no) | Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser | |
| NO993372D0 (no) | Substituerte 4-(6-fluor-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridin for behandling av CNS-forstyrrelser | |
| ATE221882T1 (de) | Neue substituierte n-methyl-n-(4-(4-(1h- benzimidazol-2-yl-amino)-piperidin-1-yl)- 2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten | |
| DE60336549D1 (de) | Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure | |
| NO20004583D0 (no) | Krystallinsk form av paroxetine | |
| NO20005351D0 (no) | Paroksetin 10-kamfersulfonat for behandling av CNS lidelser | |
| NO20005286L (no) | Behandling av generelle angstforstyrrelser med paroxetin |